SunWay Biotech Co., LTD. (1271.TWO)

TWD 82.5

(-0.6%)

Annual Income Statements

(In TWD)
Breakdown 2023 2022 2021 2020 2019
Revenue 571.11 Million 425.35 Million 380.43 Million 314.47 Million -
Cost of Revenue 334.2 Million 275.46 Million 109.32 Million 106.01 Million -
Gross Profit 236.9 Million 149.89 Million 271.11 Million 208.45 Million -
Operating Expenses 185.8 Million 111.02 Million 103.37 Million 82.58 Million -
Selling, General and Administrative Expenses 180.55 Million 111.02 Million 59.99 Million 49.59 Million -
Research and Development Expenses 6.21 Million - 43.37 Million 32.98 Million -
Other Expenses -342 Thousand 1.55 Million 2.94 Million -30 Thousand -
Cost and Expenses 520.62 Million 386.48 Million 212.69 Million 188.59 Million -
Operating Income 50.48 Million 40.42 Million 170.74 Million 125.89 Million -
Interest Expense 2.08 Million 1.15 Million 90 Thousand 195 Thousand 638 Thousand
Income Tax Expense 9.85 Million 8.28 Million 488 Thousand -15 Thousand -
Earnings before Tax 54.27 Million 39.62 Million 170.2 Million 125.69 Million -
Net Income 44.07 Million 30.04 Million 168.76 Million 125.71 Million 38.23 Million
Earnings Per Share Basic 1.47 1.51 5.10 4.02 1.23
Earnings Per Share Diluted 1.47 1.51 5.00 3.94 1.15
Weighted Average Shares Outstanding 29.9 Million 19.89 Million 33.75 Million 31.9 Million 33.24 Million
Weighted Average Shares Outstanding (Diluted) 29.97 Million 19.88 Million 33.78 Million 31.94 Million 33.17 Million
Gross Margin 0.41 0.35 0.71 0.66 -
EBIT Margin 0.15 0.11 0.50 0.46 -
Profit Margin 0.08 0.07 0.44 0.40 0.22
EBITDA 83.46 Million 48.17 Million 190.47 Million 146.22 Million 61.92 Million
Earnings Before Tax Margin 0.09 0.10 0.45 0.40 -

Income Statement Charts